Kerala Ayurveda [KERALAYUR] vs Aarti Drugs [AARTIDRUGS] Detailed Stock Comparison
Kerala Ayurveda
BSE
Loading...
Aarti Drugs
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Kerala Ayurveda wins in 3 metrics, Aarti Drugs wins in 16 metrics, with 0 ties. Aarti Drugs appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Kerala Ayurveda | Aarti Drugs | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 617.16 | 22.81 | Aarti Drugs |
| Price-to-Book Ratio | 58.76 | 3.14 | Aarti Drugs |
| Debt-to-Equity Ratio | 548.18 | 44.92 | Aarti Drugs |
| PEG Ratio | 1.28 | 0.36 | Aarti Drugs |
| EV/EBITDA | 823.51 | 16.76 | Aarti Drugs |
| Profit Margin (TTM) | -9.83% | 7.80% | Aarti Drugs |
| Operating Margin (TTM) | 9.54% | 10.11% | Aarti Drugs |
| EBITDA Margin (TTM) | 9.54% | 10.11% | Aarti Drugs |
| Return on Equity | -114.03% | 12.28% | Aarti Drugs |
| Return on Assets (TTM) | -11.42% | 6.53% | Aarti Drugs |
| Free Cash Flow (TTM) | $-84.95M | $674.20M | Aarti Drugs |
| Dividend Yield | N/A | 0.22% | N/A |
| 1-Year Return | 54.87% | -14.34% | Kerala Ayurveda |
| Price-to-Sales Ratio (TTM) | 4.46 | 1.77 | Aarti Drugs |
| Enterprise Value | $5.93B | $49.56B | Aarti Drugs |
| EV/Revenue Ratio | 4.48 | 2.05 | Aarti Drugs |
| Gross Profit Margin (TTM) | 75.65% | 36.77% | Kerala Ayurveda |
| Revenue per Share (TTM) | $113 | $265 | Aarti Drugs |
| Earnings per Share (Diluted) | $-11.25 | $20.65 | Aarti Drugs |
| Beta (Stock Volatility) | 0.08 | 0.21 | Kerala Ayurveda |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Kerala Ayurveda vs Aarti Drugs Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Kerala Ayurveda | -2.05% | -4.11% | -13.57% | 22.67% | 47.99% | 12.42% |
| Aarti Drugs | 2.56% | -4.13% | -10.00% | 1.76% | 27.10% | 6.05% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Kerala Ayurveda | 54.87% | 578.17% | 674.37% | 853.76% | 848.27% | 515.64% |
| Aarti Drugs | -14.34% | 10.27% | -34.08% | 237.25% | 2,680.94% | 2,426.41% |
Performance & Financial Health Analysis: Kerala Ayurveda vs Aarti Drugs
| Metric | KERALAYUR | AARTIDRUGS |
|---|---|---|
| Market Information | ||
| Market Cap | ₹5.91B | ₹42.99B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 6,185 | 149,023 |
| 90 Day Avg. Volume | 25,675 | 593,839 |
| Last Close | ₹494.05 | ₹483.05 |
| 52 Week Range | ₹250.00 - ₹625.00 | ₹312.00 - ₹635.00 |
| % from 52W High | -20.95% | -23.93% |
| All-Time High | ₹625.00 (Jul 01, 2025) | ₹1,026.95 (Oct 05, 2020) |
| % from All-Time High | -20.95% | -52.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.38% | 0.06% |
| Quarterly Earnings Growth | 5.29% | 0.62% |
| Financial Health | ||
| Profit Margin (TTM) | -0.10% | 0.08% |
| Operating Margin (TTM) | 0.10% | 0.10% |
| Return on Equity (TTM) | -1.14% | 0.12% |
| Debt to Equity (MRQ) | 548.18 | 44.92 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹8.36 | ₹149.84 |
| Cash per Share (MRQ) | ₹3.27 | ₹2.48 |
| Operating Cash Flow (TTM) | ₹43.75M | ₹2.83B |
| Levered Free Cash Flow (TTM) | ₹-146,991,000 | ₹1.68B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.22% |
| Last 12-Month Dividend | N/A | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Kerala Ayurveda vs Aarti Drugs
| Metric | KERALAYUR | AARTIDRUGS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 617.16 | 22.81 |
| Forward P/E | N/A | 14.86 |
| PEG Ratio | 1.28 | 0.36 |
| Price to Sales (TTM) | 4.46 | 1.77 |
| Price to Book (MRQ) | 58.76 | 3.14 |
| Market Capitalization | ||
| Market Capitalization | ₹5.91B | ₹42.99B |
| Enterprise Value | ₹5.93B | ₹49.56B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.48 | 2.05 |
| Enterprise to EBITDA | 823.51 | 16.76 |
| Risk & Other Metrics | ||
| Beta | 0.08 | 0.21 |
| Book Value per Share (MRQ) | ₹8.36 | ₹149.84 |
Financial Statements Comparison: Kerala Ayurveda vs Aarti Drugs
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | KERALAYUR | AARTIDRUGS |
|---|---|---|
| Revenue/Sales | ₹286.12M | ₹6.77B |
| Cost of Goods Sold | ₹69.68M | ₹4.37B |
| Gross Profit | ₹216.44M | ₹2.40B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-58.38M | ₹784.50M |
| EBITDA | ₹52.88M | ₹951.90M |
| Pre-Tax Income | ₹28.11M | ₹711.50M |
| Income Tax | ₹7.83M | ₹83.80M |
| Net Income (Profit) | ₹20.28M | ₹627.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | KERALAYUR | AARTIDRUGS |
|---|---|---|
| Cash & Equivalents | ₹33.89M | ₹45.80M |
| Total Current Assets | ₹407.67M | ₹13.38B |
| Total Current Liabilities | ₹879.75M | ₹8.37B |
| Long-Term Debt | ₹222.20M | ₹2.86B |
| Total Shareholders Equity | ₹128.91M | ₹13.69B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹310.45M | ₹8.59B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | KERALAYUR | AARTIDRUGS |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | KERALAYUR | AARTIDRUGS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 6,185 | 149,023 |
| Average Daily Volume (90 Day) | 25,675 | 593,839 |
| Shares Outstanding | 12.03M | 91.27M |
| Float Shares | 8.74M | 35.46M |
| % Held by Insiders | 0.69% | 0.61% |
| % Held by Institutions | 0.00% | 0.11% |
Dividend Analysis & Yield Comparison: Kerala Ayurveda vs Aarti Drugs
| Metric | KERALAYUR | AARTIDRUGS |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹1.00 |
| Last 12-Month Dividend Yield | N/A | 0.22% |
| 3-Year Avg Annual Dividend | N/A | ₹1.00 |
| 3-Year Avg Dividend Yield | N/A | 0.23% |
| 3-Year Total Dividends | N/A | ₹3.00 |
| Ex-Dividend Date | N/A | Feb 04, 2025 |